BeStock  
Stocks › Biotechnology › PHAT

Phathom Pharmaceuticals PHAT

US equityMarket cap rank #3686Biotechnology
$4.66 −$0.42 (-8.27%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.66 0.00%
Open$4.93
Prev close$5.08
Day range$4.62 – $5.15
Volume1.33M
Market cap$378.82M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

PHAT at a glance

Phathom Pharmaceuticals (PHAT) is trading at $4.66, down 8.27% on the day. Its market value of $378.82M makes it the 3686th largest of the 3753 companies we follow.

It is close to the bottom of its 52-week range ($4.62 to $18.31), 74.5% under the high. Holders are behind 68.9% over twelve months, and down 46.2% across the last three months.

On the chart it has slipped under both the 50-day ($6.61) and 200-day ($9.82) moving averages; RSI is 31, and the last 30 sessions moved at roughly 98% annualized volatility.

Revenue for the quarter ended Sep 2026 was $84.72M, up 71.1% from a year earlier, and a net loss of $13.90M.

6 analysts follow the stock and the average call is "buy". The mean target, $16.90, sits 262.7% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$4.00 / $4.71
Average price today$4.76
Volume1.33MAvg (90d) 1.48M
Turnover$6.33M
Turnover rate2.02%of shares outstanding
Volume ratio1.04vs. recent average pace
Day amplitude10.43%
Market cap$378.82M
Float market cap$307.23M
Shares outstanding65.93M
EPS (TTM)-$3.03
P/B-1.09
Book value / share-$4.28
Net profit (TTM)-$246.31M
Net assets-$347.60M
30-day volatility98.0%annualized
Avg daily range (ATR)10.34%of price, 14 days
Max drawdown (1y)-74.2%-74.2% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

6 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 4.1 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation20.2
Growth—
Profitability16.1
Momentum2.2
Financial health6.4
Analyst view89.9

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$16.90+262.7% vs. current price
Consensus ratingBuy6 analysts covering
Morningstar fair value$5.47Price is below fair value

Wall Street’s average 12-month target is $16.90, 262.7% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $5.47, so shares trade 14.9% below that estimate. On earnings multiple, it sits in the 4th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-8.3%
1 week
-23.1%
1 month
-33.5%
3 months
-46.2%
6 months
-58.9%
Year to date
-71.9%
1 year
-68.9%
Day range
$4.62$5.15
52-week range
$4.62$18.31

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-18.0%Bearish
Price vs 50-day average-29.5%Bearish
Price vs 200-day average-52.6%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)31.1Bearish
MACD (12,26,9)-0.43Bearish
Bollinger band position-5%Neutral

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How PHAT ranks on BeStock

Market value#3668 of 3734
Closeness to 52-week high#3569 of 3724
Dollar volume today#2612 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

PHAT is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on PHAT.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on PHAT

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

PHAT stock: common questions

How is Phathom Pharmaceuticals stock doing today?

$4.66 is the latest print for PHAT, a move of -8.27% against yesterday's close of $5.08. Today's low and high so far: $4.62 and $5.15.

What is PHAT worth in total?

Equity value comes to $378.82M at the current price. By that measure it is number 3686 of the 3753 names in our coverage.

Is PHAT near its 52-week high or low?

The year's floor is $4.62 and the ceiling $18.31. Shares are 74.5% away from that ceiling.

Does Phathom Pharmaceuticals pay a dividend?

Our data shows no dividend paid by Phathom Pharmaceuticals over the trailing twelve months.

Is PHAT rated a buy by Wall Street?

Of 6 analysts, 83% say buy, 17% hold and 0% sell. Price targets average $16.90, with the most cautious at $7.50 and the most optimistic at $26.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on PHAT.

Sign in to join the discussion.

Scroll to Top